Hematological, biochemical and hematopoietic results of therapeutic doses of two antibiotics, oxytetracycline (OTC) and gentamicin (GEN), in clinically wholesome frequent carp juveniles have been studied. The fish have been divided into 4 teams: controls 1 and a pair of (untreated or injected with 0.6% NaCl resolution), and two teams handled with antibiotics (orally with 75 mg/kg OTC 4 instances each two days or injected with a single dose (four mg/kg) of GEN dissolved in 0.6% NaCl). Blood and head kidneys have been sampled from all fish three days post-treatments for hematological, biochemical and hematopoietic tissue analyses. No main alterations within the values of hematological and serum biochemical parameters occurred following administration of OTC or GEN. Glucose concentrations have been considerably decrease in each teams of fish subjected to injections (Management 2 and GEN), whereas the oxidative metabolic exercise of phagocytes elevated within the antibiotic-treated teams (considerably in OTC).
Extra alterations have been noticed in hematopoietic tissue. Immunocytochemical evaluation revealed that G triggered a big enhance within the price of cell proliferation (PCNA-positive cells) and a rise within the frequency of apoptotic cells (caspase-positive). The frequency of lymphoid lineage decreased, which was associated to a lower within the abundance of mature lymphocytes in GEN-treated fish. Percentages of neutrophilic lineage have been considerably elevated in OTC and GEN teams in comparison with controls. The obtained outcomes confirmed no appreciable hematotoxicity or hepatotoxicity of therapeutic doses of OTC and GEN to carp. MicroRNAs function potential biomarkers in varied pathological fashions, and are steady and detectable in biofluids. We investigated the urinary microRNA expression profile in a gentamicin-induced acute kidney harm canine mannequin utilizing RNA sequencing. A complete of 234 differentially expressed microRNAs have been screened after 12 consecutive days of gentamicin administration (P < 0.05).
This examine investigated antimicrobial resistance (AMR) profiles from a cohort of sufferers with bacterial keratitis handled at Sydney Eye Hospital, 1 January 2017 – 31 December 2018. These AMR profiles have been analysed within the context of the present Australian empiric regimens for topical remedy: ciprofloxacin/ofloxacin monotherapy versus mixture remedy of cefalotin/cephazolin plus gentamicin. At our Centre, combos of (i) chloramphenicol plus gentamicin and (ii) chloramphenicol plus ciprofloxacin are alternatively used, so have been additionally analysed. 300 and seventy-four isolates have been cultured prospectively: 280/374 (75%) have been gram optimistic, and 94/374 (25%) have been gram destructive.
Newly designed antimicrobial peptides with potent bioactivity and enhanced cell selectivity forestall and reverse rifampin resistance in Gram-negative micro organism
The rising prevalence of antibiotic resistance in Gram-negative micro organism requires the invention of novel efficient therapeutic methods urgently. Mastoparan-C (MP-C), a typical cationic α-helical antimicrobial peptide, possesses outstanding broad-spectrum antimicrobial exercise. Nevertheless, its excessive cytotoxicity towards regular mammalian cells precludes it for additional improvement. On this examine, to keep away from non-specific membrane lysis and examine the structure-function relationships of every amino acid of MP-C, a sequence of latest MP-C analogs have been rationally designed by amino acid substitution and peptide truncation. Three potential newly designed peptides L1G, L7A, and L1GA5Okay with wonderful bioactivity, modest cell toxicity, low resistance tendency, and reasonable stability to physiological salts and proteases have been screened out.
Furthermore, the newly designed peptides confirmed synergy or additive results towards Gram-negative micro organism, after they mixed with standard antibiotics gentamicin, rifampin, and polymyxin B. The outcomes from the time-kill kinetics, outer/inside membrane permeabilization, scanning electron microscope (SEM), and movement cytometry demonstrated that the newly designed peptides might kill micro organism quickly by membrane destruction and intracellular contents leakage in a focus and time-dependent method. Particularly, essentially the most cell-selective peptide L1GA5Okay exhibited potent antimicrobial exercise towards rifampin-resistant E. coli (RRE) and prevented the emergence of rifampin resistance in Enterobacter.
Moreover, L1GA5Okay was able to reversing rifampin resistance in RRE by way of the outer membrane permeabilization when utilized in mixture with rifampin. Collectively, our outcomes steered that the newly designed peptides are hopeful antibiotic options, and the utilization of them as an adjuvant to stop and reverse antibiotic resistance is a promising technique for tackling the chance of drug-resistant Gram-negative micro organism.
Diminished Efflux Pumps Expression of Pseudomonas Aeruginosa with Satureja Khuzistanica Important Oil
Background: Efflux pumps comparable to MexEF-OprN and mexXY-OprM play an necessary position within the resistance of Pseudomonas Aeruginosa (P. aeruginosa) to antibiotics. The current examine aimed to evaluate the lowered expression of efflux pump genes of P. aeruginosa with Satureja Khuzistanica important oil (SKEO).
Strategies: The current cross-sectional examine was carried out in 2016 on the Microbiology Laboratory of Baqiyatallah College of Medical Sciences, Tehran, Iran. The disk diffusion methodology was used for susceptibility testing of gentamicin and norfloxacin. Minimal inhibitory focus (MIC) was decided for gentamicin and norfloxacin. The antibacterial efficacy of SKEO was outlined by figuring out the MIC values utilizing the microdilution methodology. In vitro, the synergistic interplay of SKEO mixed with gentamicin or norfloxacin was examined through checkerboard assay and outlined as a fractional inhibitory focus index. The reverse transcription-polymerase chain response approach was used to measure adjustments within the expression of the efflux pump genes. The information have been analyzed utilizing SPSS software program model 16.0, and P<0.05 was thought-about statistically important.
Gentamicin Antibody |
|||
| abx021013-1mg | Abbexa | 1 mg | EUR 577.2 |
Gentamicin Antibody |
|||
| 20-abx210193 | Abbexa |
|
|
Gentamicin-BSA |
|||
| 80-1453 | Fitzgerald | 1 mg | EUR 781.2 |
|
Description: BSA conjugated Gentamicin Hapten |
|||
Gentamicin-BSA |
|||
| 80-1454 | Fitzgerald | 1 mg | EUR 781.2 |
|
Description: BSA conjugated Gentamicin Hapten |
|||
Gentamicin-OVA |
|||
| 80-1455 | Fitzgerald | 1 mg | EUR 781.2 |
|
Description: OVA conjugated Gentamicin Hapten |
|||
Gentamicin-OVA |
|||
| 80-1456 | Fitzgerald | 1 mg | EUR 781.2 |
|
Description: OVA conjugated Gentamicin Hapten |
|||
Gentamicin-BSA |
|||
| 80-IG10 | Fitzgerald | 25 mg | EUR 457.2 |
|
Description: Conjugated Gentamicin-BSA hapten |
|||
Gentamicin(GM) |
|||
| AG022 | Unibiotest | 1 mg | EUR 627.6 |
Gentamicin(GM) |
|||
| AT022 | Unibiotest | 1mg | EUR 1134 |
Gentamicin [KLH] |
|||
| DAG4484 | Creative Diagnostics | 1mg | EUR 1248 |
Gentamicin [HRP] |
|||
| DAGA-032H | Creative Diagnostics | 1mg | EUR 1248 |
Gentamicin (sulfate) |
|||
| HY-A0276 | MedChemExpress | 500mg | EUR 142.8 |
Gentamicin sulfate |
|||
| GA7939-10G | Glentham Life Sciences | 10 g | EUR 122.4 |
Gentamicin sulfate |
|||
| GA7939-1G | Glentham Life Sciences | 1 g | EUR 55.2 |
Gentamicin sulfate |
|||
| GA7939-25G | Glentham Life Sciences | 25 g | EUR 189.6 |
Gentamicin sulfate |
|||
| GA7939-5G | Glentham Life Sciences | 5 g | EUR 93.6 |
Gentamicin sulfate |
|||
| B1270-1G | Biovision | each | EUR 170.4 |
Gentamicin sulfate |
|||
| B1270-25G | Biovision | each | EUR 1136.4 |
Gentamicin sulfate |
|||
| B1270-5G | Biovision | each | EUR 405.6 |
Gentamicin Solution, Gentamicin Solution, 50 mg/mL |
|||
| CCM1123-010 | Bio Basic | 10 mL | EUR 76.86 |
Gentamicin ELISA kit |
|||
| 55R-2233 | Fitzgerald | 1 kit | EUR 837.6 |
|
Description: Gentamicin ELISA kit for use in research laboratory |
|||
Gentamicin monoclonal antibody |
|||
| 10R-11497 | Fitzgerald | 1 mg | EUR 1332 |
|
Description: Mouse anti- Gentamicin monoclonal antibody |
|||
Gentamicin sulfate salt |
|||
| 20-abx082235 | Abbexa |
|
|
Gentamicin (GTM) Antibody |
|||
| 20-abx175177 | Abbexa |
|
|
Gentamicin ELISA Kit |
|||
| DEIA047 | Creative Diagnostics | 96T | EUR 1238.4 |
|
Description: This kit can be used in quantitative and qualitative analysis of gentamicin residue in vaccine and cell culture. |
|||
Gentamicin, 50mg/ml |
|||
| CA003-001 | GenDepot | 10ml | EUR 109.2 |
Gentamicin Sulfate USP |
|||
| G006-25G | TOKU-E | 25 g | EUR 470.4 |
Gentamicin Sulfate USP |
|||
| G006-5G | TOKU-E | 5 g | EUR 199.2 |
Gentamicin Sulfate EP |
|||
| G007-25G | TOKU-E | 25 g | EUR 478.8 |
Gentamicin Sulfate EP |
|||
| G007-5G | TOKU-E | 5 g | EUR 219.6 |
Gentamicin ELISA Kit |
|||
| K4206-100 | Biovision | each | EUR 1188 |
Minoxidil Sulphate |
|||
| abx184735-1g | Abbexa | 1 g | EUR 944.4 |
Copper Sulphate |
|||
| abx186748-5g | Abbexa | 5 g | EUR 226.8 |
Tobramycin sulphate |
|||
| GA2734-100MG | Glentham Life Sciences | 100 mg | EUR 84 |
Tobramycin sulphate |
|||
| GA2734-1G | Glentham Life Sciences | 1 g | EUR 274.8 |
Tobramycin sulphate |
|||
| GA2734-250MG | Glentham Life Sciences | 250 mg | EUR 132 |
Capastat sulphate |
|||
| GA2874-1G | Glentham Life Sciences | 1 g | EUR 160.8 |
Capastat sulphate |
|||
| GA2874-5G | Glentham Life Sciences | 5 g | EUR 438 |
Atazanavir sulphate |
|||
| GP7849-100MG | Glentham Life Sciences | 100 mg | EUR 103.2 |
Atazanavir sulphate |
|||
| GP7849-1G | Glentham Life Sciences | 1 g | EUR 265.2 |
Atazanavir sulphate |
|||
| GP7849-250MG | Glentham Life Sciences | 250 mg | EUR 151.2 |
Gentamicin ELISA Kit (OKAO00127) |
|||||||||||||
| OKAO00127 | Aviva Systems Biology | 96 Wells | EUR 638.4 | ||||||||||
|
Description: Description of target: Gentamicin is a complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.;Species reactivity: General;Application: ;Assay info: Assay Methodology: Competitive Inhibition ELISA;Sensitivity:
|
|||||||||||||
Gentamicin C1 pentaacetate salt |
|||
| GA1270-10MG | Glentham Life Sciences | 10 mg | EUR 783.6 |
Gentamicin C1 pentaacetate salt |
|||
| GA1270-1MG | Glentham Life Sciences | 1 mg | EUR 204 |
Gentamicin C2 pentaacetate salt |
|||
| GA2476-5MG | Glentham Life Sciences | 5 mg | EUR 418.8 |
Gentamicin C1a pentaacetate salt |
|||
| GA4559-10MG | Glentham Life Sciences | 10 mg | EUR 514.8 |
Gentamicin C1a pentaacetate salt |
|||
| GA4559-25MG | Glentham Life Sciences | 25 mg | EUR 964.8 |
0.1g Gentamicin Sulfate Powder |
|||
| 61-098-RA | Scientific Laboratory Supplies | EACH | EUR 58.37 |
1g Gentamicin Sulfate Powder |
|||
| 61-098-RF | Scientific Laboratory Supplies | EACH | EUR 76.38 |
Sd Gentamicin Gm-10 |
|||
| 231299 | Scientific Laboratory Supplies | PK10 | EUR 50.86 |
DHEA Sulphate antibody |
|||
| 20-1424 | Fitzgerald | 100 ul | EUR 788.4 |
|
Description: Sheep polyclonal DHEA Sulphate antibody |
|||
Indinavir sulphate hydrate |
|||
| GP6821-100MG | Glentham Life Sciences | 100 mg | EUR 217.2 |
Indinavir sulphate hydrate |
|||
| GP6821-10MG | Glentham Life Sciences | 10 mg | EUR 80.4 |
Indinavir sulphate hydrate |
|||
| GP6821-50MG | Glentham Life Sciences | 50 mg | EUR 151.2 |
Mouse Anti Gentamicin Monoclonal Antibody |
|||
| DMABT-54913MG | Creative Diagnostics | 1 mg | EUR 920.4 |
Mouse Anti Gentamicin Monoclonal Antibody |
|||
| DMABT-54914MG | Creative Diagnostics | 1 mg | EUR 920.4 |
Sheep Anti Gentamicin Polyclonal Antibody |
|||
| DPBT-68266SG | Creative Diagnostics | 0.5 ml | EUR 920.4 |
Gentamicin C1 Sulfate EvoPure® |
|||
| G031-10MG | TOKU-E | 10 mg | EUR 804 |
Gentamicin C1a sulfate EvoPure® |
|||
| G032-10MG | TOKU-E | 10 mg | EUR 804 |
Gentamicin C2 sulfate EvoPure® |
|||
| G033-10MG | TOKU-E | 10 mg | EUR 804 |
Gentamicin C2a sulfate EvoPure® |
|||
| G034-10MG | TOKU-E | 10 mg | EUR 804 |
Gentamicin A sulfate EvoPure® |
|||
| G035-10MG | TOKU-E | 10 mg | EUR 456 |
Gentamicin X2 sulfate EvoPure® |
|||
| G036-2.5MG | TOKU-E | 2.5 mg | EUR 36 |
Gentamicin X2 sulfate EvoPure® |
|||
| G036-PleaseContactusforPricing | TOKU-E | Please Contact us for Pricing | EUR 36 |
Gentamicin C2b sulfate EvoPure® |
|||
| G062-10MG | TOKU-E | 10 mg | EUR 615.6 |
10mL Gentamicin Sulfate Liquid 5 |
|||
| 30-005-CR | Scientific Laboratory Supplies | PK10 | EUR 523.26 |
Gentamicin (serum/urine) ELISA Kit |
|||
| K4315-100 | Biovision | each | EUR 907.2 |
GTTR [Texas Red gentamicin conjugate] |
|||
| 24300 | AAT Bioquest | 100 ug | EUR 203 |
GTTR [Texas Red gentamicin conjugate] |
|||
| 24301 | AAT Bioquest | 1 mg | EUR 989 |
Heparan Sulphate Proteoglycan antibody |
|||
| 10R-8070 | Fitzgerald | 100 ug | EUR 489.6 |
|
Description: Rat monoclonal Heparan Sulphate Proteoglycan antibody |
|||
5g G418 Sulphate powder |
|||
| 61-234-RG | Scientific Laboratory Supplies | EACH | EUR 400.14 |
100ML Sulphate Standard Solution |
|||
| 5002800C | Scientific Laboratory Supplies | 100ML | EUR 74.1 |
CP 0.05M Zinc Sulphate |
|||
| CP60051 | Scientific Laboratory Supplies | 1L | EUR 49.02 |
Zinc Sulphate 1000mg/L |
|||
| ZN10001 | Scientific Laboratory Supplies | 1L | EUR 183.54 |
Zinc Sulphate 220mg/L |
|||
| ZN221 | Scientific Laboratory Supplies | 1L | EUR 128.82 |
Heparan Sulphate Proteoglycan(A7L6) Antibody |
|||
| BNC040315-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Heparan Sulphate Proteoglycan(A7L6), CF405S conjugate, Concentration: 0.1mg/mL |
|||
Heparan Sulphate Proteoglycan(A7L6) Antibody |
|||
| BNC040315-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Heparan Sulphate Proteoglycan(A7L6), CF405S conjugate, Concentration: 0.1mg/mL |
|||
Heparan Sulphate Proteoglycan(A7L6) Antibody |
|||
| BNC050315-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Heparan Sulphate Proteoglycan(A7L6), CF405M conjugate, Concentration: 0.1mg/mL |
|||
Heparan Sulphate Proteoglycan(A7L6) Antibody |
|||
| BNC050315-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Heparan Sulphate Proteoglycan(A7L6), CF405M conjugate, Concentration: 0.1mg/mL |
|||
Heparan Sulphate Proteoglycan(A7L6) Antibody |
|||
| BNCAP0315-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Heparan Sulphate Proteoglycan(A7L6), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Heparan Sulphate Proteoglycan(A7L6) Antibody |
|||
| BNCAP0315-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Heparan Sulphate Proteoglycan(A7L6), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Heparan Sulphate Proteoglycan(A7L6) Antibody |
|||
| BNCB0315-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Heparan Sulphate Proteoglycan(A7L6), Biotin conjugate, Concentration: 0.1mg/mL |
|||
Heparan Sulphate Proteoglycan(A7L6) Antibody |
|||
| BNCB0315-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Heparan Sulphate Proteoglycan(A7L6), Biotin conjugate, Concentration: 0.1mg/mL |
|||
Heparan Sulphate Proteoglycan(A7L6) Antibody |
|||
| BNCP0315-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against Heparan Sulphate Proteoglycan(A7L6), PerCP conjugate, Concentration: 0.1mg/mL |
|||
Heparan Sulphate Proteoglycan(A7L6) Antibody |
|||
| BNCR0315-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against Heparan Sulphate Proteoglycan(A7L6), RPE conjugate, Concentration: 0.1mg/mL |
|||
Heparan Sulphate Proteoglycan(A7L6) Antibody |
|||
| BNC940315-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Heparan Sulphate Proteoglycan(A7L6), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Heparan Sulphate Proteoglycan(A7L6) Antibody |
|||
| BNC940315-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Heparan Sulphate Proteoglycan(A7L6), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Heparan Sulphate Proteoglycan(A7L6) Antibody |
|||
| BNCA0315-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against Heparan Sulphate Proteoglycan(A7L6), APC conjugate, Concentration: 0.1mg/mL |
|||
Heparan Sulphate Proteoglycan(A7L6) Antibody |
|||
| BNC810315-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Heparan Sulphate Proteoglycan(A7L6), CF680R conjugate, Concentration: 0.1mg/mL |
|||
Heparan Sulphate Proteoglycan(A7L6) Antibody |
|||
| BNC810315-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Heparan Sulphate Proteoglycan(A7L6), CF680R conjugate, Concentration: 0.1mg/mL |
|||
Heparan Sulphate Proteoglycan(A7L6) Antibody |
|||
| BNUB0315-100 | Biotium | 100uL | EUR 250.8 |
|
Description: Primary antibody against Heparan Sulphate Proteoglycan(A7L6), Concentration: 0.2mg/mL |
|||
Heparan Sulphate Proteoglycan(A7L6) Antibody |
|||
| BNUB0315-500 | Biotium | 500uL | EUR 549.6 |
|
Description: Primary antibody against Heparan Sulphate Proteoglycan(A7L6), Concentration: 0.2mg/mL |
|||
Heparan Sulphate Proteoglycan(A7L6) Antibody |
|||
| BNCH0315-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Heparan Sulphate Proteoglycan(A7L6), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Heparan Sulphate Proteoglycan(A7L6) Antibody |
|||
| BNCH0315-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Heparan Sulphate Proteoglycan(A7L6), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Heparan Sulphate Proteoglycan(A7L6) Antibody |
|||
| BNC880315-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Heparan Sulphate Proteoglycan(A7L6), CF488A conjugate, Concentration: 0.1mg/mL |
|||
Heparan Sulphate Proteoglycan(A7L6) Antibody |
|||
| BNC880315-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Heparan Sulphate Proteoglycan(A7L6), CF488A conjugate, Concentration: 0.1mg/mL |
|||
Heparan Sulphate Proteoglycan(A7L6) Antibody |
|||
| BNC680315-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Heparan Sulphate Proteoglycan(A7L6), CF568 conjugate, Concentration: 0.1mg/mL |
|||
Heparan Sulphate Proteoglycan(A7L6) Antibody |
|||
| BNC680315-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Heparan Sulphate Proteoglycan(A7L6), CF568 conjugate, Concentration: 0.1mg/mL |
|||
Heparan Sulphate Proteoglycan(A7L6) Antibody |
|||
| BNC470315-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Heparan Sulphate Proteoglycan(A7L6), CF647 conjugate, Concentration: 0.1mg/mL |
|||
Heparan Sulphate Proteoglycan(A7L6) Antibody |
|||
| BNC470315-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Heparan Sulphate Proteoglycan(A7L6), CF647 conjugate, Concentration: 0.1mg/mL |
|||
Heparan Sulphate Proteoglycan(A7L6) Antibody |
|||
| BNC430315-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Heparan Sulphate Proteoglycan(A7L6), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Heparan Sulphate Proteoglycan(A7L6) Antibody |
|||
| BNC430315-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Heparan Sulphate Proteoglycan(A7L6), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Heparan Sulphate Proteoglycan(A7L6) Antibody |
|||
| BNC610315-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Heparan Sulphate Proteoglycan(A7L6), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Heparan Sulphate Proteoglycan(A7L6) Antibody |
|||
| BNC610315-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Heparan Sulphate Proteoglycan(A7L6), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Heparan Sulphate Proteoglycan(A7L6) Antibody |
|||
| BNC800315-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Heparan Sulphate Proteoglycan(A7L6), CF680 conjugate, Concentration: 0.1mg/mL |
|||
Heparan Sulphate Proteoglycan(A7L6) Antibody |
|||
| BNC800315-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Heparan Sulphate Proteoglycan(A7L6), CF680 conjugate, Concentration: 0.1mg/mL |
|||
Heparan Sulphate Proteoglycan(A7L6) Antibody |
|||
| BNC400315-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Heparan Sulphate Proteoglycan(A7L6), CF640R conjugate, Concentration: 0.1mg/mL |
|||
Heparan Sulphate Proteoglycan(A7L6) Antibody |
|||
| BNC400315-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Heparan Sulphate Proteoglycan(A7L6), CF640R conjugate, Concentration: 0.1mg/mL |
|||
Heparan Sulphate Proteoglycan(A7L6) Antibody |
|||
| BNC550315-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Heparan Sulphate Proteoglycan(A7L6), CF555 conjugate, Concentration: 0.1mg/mL |
|||
Heparan Sulphate Proteoglycan(A7L6) Antibody |
|||
| BNC550315-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Heparan Sulphate Proteoglycan(A7L6), CF555 conjugate, Concentration: 0.1mg/mL |
|||
Heparan Sulphate Proteoglycan(A7L6) Antibody |
|||
| BNC700315-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Heparan Sulphate Proteoglycan(A7L6), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Heparan Sulphate Proteoglycan(A7L6) Antibody |
|||
| BNC700315-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Heparan Sulphate Proteoglycan(A7L6), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Heparan Sulphate Proteoglycan(A7L6) Antibody |
|||
| BNUM0315-50 | Biotium | 50uL | EUR 474 |
|
Description: Primary antibody against Heparan Sulphate Proteoglycan(A7L6), 1mg/mL |
|||
Indoxyl Sulphate ELISA KIT|Human |
|||
| EF006793 | Lifescience Market | 96 Tests | EUR 826.8 |
EP Reagent 0.1M Cerium Sulphate |
|||
| 3001100 | Scientific Laboratory Supplies | 1L | EUR 159.6 |
EP Reagent 0.1M Zinc Sulphate |
|||
| 3008600 | Scientific Laboratory Supplies | 1L | EUR 72.96 |
EP Reagent Calcium Sulphate Sol. |
|||
| 1015201 | Scientific Laboratory Supplies | 1L | EUR 161.88 |
Sulphate Cuvette Test 150-900MG |
|||
| LCK353 | Scientific Laboratory Supplies | EACH | EUR 151.94 |
Sodium dodecyl sulphate (SDS) 0.5 g |
|||
| 09-2026-50 | Medicago | 0,5 g | EUR 81.6 |
G418 SULPHATE (LIQUID, 50 MG/ML) |
|||
| 30-234-CR | CORNING | 20 mL/pk | EUR 116.4 |
|
Description: Media Catalog; Cell Culture Reagents |
|||
Bis(2-amino-1H-imidazole) sulphate |
|||
| 20-abx182378 | Abbexa |
|
|
Adenine sulphate, dihydrate (Adenine hemisulfate salt) |
|||
| AD0028 | Bio Basic | 25g | EUR 76.7 |
Goat Heparan Sulphate Proteoglycan ELISA kit |
|||
| E06H0130-192T | BlueGene | 192 tests | EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Goat Heparan Sulphate Proteoglycan in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Goat Heparan Sulphate Proteoglycan ELISA kit |
|||
| E06H0130-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Goat Heparan Sulphate Proteoglycan in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Goat Heparan Sulphate Proteoglycan ELISA kit |
|||
| E06H0130-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Goat Heparan Sulphate Proteoglycan in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Rabbit Heparan Sulphate Proteoglycan ELISA kit |
|||
| E04H0130-192T | BlueGene | 192 tests | EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Rabbit Heparan Sulphate Proteoglycan in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Rabbit Heparan Sulphate Proteoglycan ELISA kit |
|||
| E04H0130-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Rabbit Heparan Sulphate Proteoglycan in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Rabbit Heparan Sulphate Proteoglycan ELISA kit |
|||
| E04H0130-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Rabbit Heparan Sulphate Proteoglycan in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Human Heparan Sulphate Proteoglycan ELISA kit |
|||
| E01H0130-192T | BlueGene | 192 tests | EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Human Heparan Sulphate Proteoglycan in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Human Heparan Sulphate Proteoglycan ELISA kit |
|||
| E01H0130-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Human Heparan Sulphate Proteoglycan in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Human Heparan Sulphate Proteoglycan ELISA kit |
|||
| E01H0130-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Human Heparan Sulphate Proteoglycan in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Mouse Heparan Sulphate Proteoglycan ELISA kit |
|||
| E03H0130-192T | BlueGene | 192 tests | EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Mouse Heparan Sulphate Proteoglycan in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Mouse Heparan Sulphate Proteoglycan ELISA kit |
|||
| E03H0130-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Mouse Heparan Sulphate Proteoglycan in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Mouse Heparan Sulphate Proteoglycan ELISA kit |
|||
| E03H0130-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Mouse Heparan Sulphate Proteoglycan in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Pig Heparan Sulphate Proteoglycan ELISA kit |
|||
| E07H0130-192T | BlueGene | 192 tests | EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Porcine Heparan Sulphate Proteoglycan in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Pig Heparan Sulphate Proteoglycan ELISA kit |
|||
| E07H0130-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Porcine Heparan Sulphate Proteoglycan in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Pig Heparan Sulphate Proteoglycan ELISA kit |
|||
| E07H0130-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Porcine Heparan Sulphate Proteoglycan in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Monkey Heparan Sulphate Proteoglycan ELISA kit |
|||
| E09H0130-192T | BlueGene | 192 tests | EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Monkey Heparan Sulphate Proteoglycan in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Monkey Heparan Sulphate Proteoglycan ELISA kit |
|||
| E09H0130-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Monkey Heparan Sulphate Proteoglycan in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Monkey Heparan Sulphate Proteoglycan ELISA kit |
|||
| E09H0130-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Monkey Heparan Sulphate Proteoglycan in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Rat Heparan Sulphate Proteoglycan ELISA kit |
|||
| E02H0130-192T | BlueGene | 192 tests | EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Rat Heparan Sulphate Proteoglycan in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Rat Heparan Sulphate Proteoglycan ELISA kit |
|||
| E02H0130-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Rat Heparan Sulphate Proteoglycan in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Rat Heparan Sulphate Proteoglycan ELISA kit |
|||
| E02H0130-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Rat Heparan Sulphate Proteoglycan in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Outcomes: The MIC values of SKEO have been within the vary of 6 to 12 µg/mL. Within the presence of sub-inhibitory concentrations (1.16 to 2 MIC) of SKEO, synergistic results have been revealed utilizing the checkerboard methodology. The impact of norfloxacin and gentamicin elevated as much as 8-fold. The expression of mexY and mexE was lowered after therapy with SKEO.
